National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs

NCCN Academy for Excellence & Leadership
in Oncology™:
School of Pharmaceutical & Biotech Business

Academy Date > March 20, 2019 > Enroll Now!

Academy Location > Rosen Shingle Creek | Orlando, FL


The NCCN Academy for Excellence & Leadership in Oncology: School of Pharmaceutical & Biotech Business coinciding with the NCCN 2019 Annual Conference will take place on Wednesday, March 20, 2019 in Orlando, Florida.

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Participants improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Please check back often for additional updates regarding this program. If you have any questions, please contact Elyse Becker, Senior Business Development Specialist.


8:05 AM – 2:30 PM
(Breakfast and registration begin at 7:30 AM)


Clifford Goodman, PhD
Senior Vice President
The Lewin Group




7:30 – 8:00 AM


8:00 – 8:10 AM

C. Lyn Fitzgerald, MJ
Senior Vice President, U.S. & Global Development
National Comprehensive Cancer Network

8:15 – 10:00 AM

Module I: Models for Successful Collaboration in Practice Management and Health Information Technology

Bruce Gould, MD (Invited)
Medical Director
Northwest Georgia Oncology Centers, P.C.

Jonathan Hirsch (Invited)

Barbara McAnemy, MD
American Medical Association

Charles Saunders, MD (Invited)
Chief Executive Officer
Integra Connect

10:05 – 10:20 AM


10:25 – 11:55 AM

Module II: Meet the NCCN Guidelines® Panel Experts

Wui-Jin Koh, MD
Senior Vice President/Chief Medical Officer
National Comprehensive Cancer Network

Michael Streiff
Associate Professor of Medicine
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chair, NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease Panel

David Teachey, MD
Associate Professor
Children’s Hospital of Philadelphia
Abramson Cancer Center at the University of Pennsylvania
Member, NCCN Guidelines for Pediatric Acute Lymphoblastic Leukemia

Andrew Zelenetz, MD, PhD
Medical Director, Quality Informatics
Memorial Sloan Kettering Cancer Center
Chair, NCCN Guidelines for B-Cell Lymphoma Panel

12:00 – 12:45 PM


12:50 – 2:20 PM

Module III: Watching P’s and Q’s to Ensure Access to Quality Cancer
Care; A View from Various Influencers

Bryan Loy (Invited)
Market Medical Officer

Pamela N. Munster, MD (Invited)
Professor in Residence, Department of Medicine
Program leader Experimental Therapeutics,
Co-program leader, Center for BRCA RESEARCH
UCSF Helen Diller Family Comprehensive Cancer Center
Patient Advocate and Caregiver

Everett Neville, RPh (Invited)
EVP, Strategy, Supply Chain & Specialty
Express Scripts

Lalan Wilfong, MD
Vice President Quality Programs
Texas Oncology

2:25 - 3:30 PM

Closing Remarks

Gary Weyhmuller, MBA, SPHR
Executive Vice President/Chief Operating Officer
National Comprehensive Cancer Network


Professionals from advocacy, marketing, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

*Subject to change.



Rosen Shingle Creek
9939 Universal Blvd
Orlando, FL 32819

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.